Kronos Bio Inc expected to post a loss of 52 cents a share - Earnings Preview

Kronos Bio

11/03/2024 20:07

* Kronos Bio Inc  KRON.OQ   KRON.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 13
(estimated) for the period ending December 31 2023
    * The San Mateo California-based  company is expected to
report
revenue of $1.525 million, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Kronos Bio Inc is for a
loss
of 52 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Kronos Bio
Inc is
$4.25​, above​ its last closing price of $1.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.45       -0.51      -0.54     Missed  -5.4
 Jun. 30 2023  -0.43       -0.46      -0.52     Missed  -13
 Mar. 31 2023  -0.27       -0.44      -0.46     Missed  -3.4​
 Dec. 31 2022  -0.48       -0.59      -0.56     Beat    4.4
 ​​Sep.        -0.65       -0.65      -0.57     Beat    12.6
 30 2022                                                
 Jun. 30 2022  -0.69       -0.69      -0.59     Beat    14.7​
 Mar. 31 2022  -0.65       -0.66      -0.65     Beat    1.2
 Dec. 31 2021  -1.08       -1.10      -1.13     Missed  -2.9
 This summary was machine generated March 11 at 20:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)